Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 23;6(5):e010889.
doi: 10.1136/bmjopen-2015-010889.

Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study

Amirhossein Mozaffary  1 , Samaneh Asgari  1 , Maryam Tohidi  1 , Sara Kazempour-Ardebili  1 , Fereidoun Azizi  2 , Farzad Hadaegh  1
Affiliations

Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study

Amirhossein Mozaffary et al. BMJ Open. .

Abstract

Objective: To investigate the association between changes in fasting plasma glucose (FPG) values and incident type 2 diabetes (T2D) in a cohort of the Iranian population.

Design: Prospective cohort study.

Setting: This study was conducted within the framework of the Tehran Lipid and Glucose Study (TLGS) to investigate the association between change in FPG between baseline examination (1999-2001) and the second visit (2002-2005) with incident T2D.

Participants: A total of 3981 non-diabetic participants aged ≥20 years.

Outcome measure: T2D was defined if the participant was using antidiabetic drugs or if FPG was ≥7 mmol/L or if the 2 h post-challenge plasma glucose (2-hPCG) was ≥11.1 mmol/L.

Results: During a median follow-up of 6.17 years, after the second examination, 288 new cases of T2D were identified. In a multivariate Cox proportional hazard analysis using age as timescale, we presented a simple model including FPG change (HR 1.19, 95% CI 1.07 to 1.33) and baseline waist circumference (WC) (HR 1.004, 95% CI 1.001 to 1.008) with a discriminative power (C-index) of 72%. Furthermore, we showed that the highest quartile of FPG change enhanced the T2D risk to 1.65 (95% CI 1.2 to 2.27) compared with the lowest quartile (p for trend=0.004).The independent risk of FPG change resisted further adjustment with 2-hPCG change. Adding the 2-hPCG change only slightly increased the discriminative power of the model including FPG change and baseline value of WC (0.73% vs 0.72%). After the study population had been limited to those with normal fasting glucose/normal glucose tolerance, FPG change remained an independent predictor (HR 1.57, 95% CI 1.31 to 1.88).

Conclusions: Two measurements of FPG obtained about 3 years apart can help to identify populations at risk of incident T2D independently of important traditional risk factors and their changes, including 2-hPCG change.

Keywords: Change; Fasting plasma glucose; Incident; Type2 Diabetes.

PubMed Disclaimer

References

    1. Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metab Clin Exp 2013;62:303–14. 10.1016/j.metabol.2012.07.009 - DOI - PubMed
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14. 10.1016/j.diabres.2009.10.007 - DOI - PubMed
    1. Cowie CC, Rust KF, Byrd-Holt DD et al. . Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 2010;33:562–8. - PMC - PubMed
    1. Soriguer F, Goday A, Bosch-Comas A et al. . Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012;55:88–93. 10.1007/s00125-011-2336-9 - DOI - PMC - PubMed
    1. Carstensen B, Kristensen JK, Ottosen P et al. . The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008;51:2187–96. 10.1007/s00125-008-1156-z - DOI - PubMed